Pegcetacoplan compared with supportive care for 26 weeks for participants with paroxysmal nocturnal hemoglobinuria: a plain language summary

In the PRINCE study, adults with paroxysmal nocturnal hemoglobinuria (PNH) who had not recently taken a C5 complement inhibitor medicine received pegcetacoplan or supportive care. Pegcetacoplan reduced hemolysis better than supportive care and was well tolerated.

Uloženo v:

Podrobná bibliografie
Vydáno v:	Future Rare Diseases Ročník 4; číslo 1
Hlavní autoři:	Ming Wong, Raymond Siu, Navarro-Cabrera, Juan Ramon, Comia, Narcisa Sonia, Goh, Yeow Tee, Idrobo, Henry, Kongkabpan, Daolada, Gómez-Almaguer, David, Al-Adhami, Mohammed, Ajayi, Temitayo, Alvarenga, Paulo, Savage, Jessica, Deschatelets, Pascal, Francois, Cedric, Grossi, Federico, Dumagay, Teresita
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Future Medicine Ltd 31.12.2024
Témata:	anemia lay summary paroxysmal nocturnal hemoglobinuria pegcetacoplan plain language summary
ISSN:	2399-5262, 2399-5270, 2399-5270
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Popis
Shrnutí:	In the PRINCE study, adults with paroxysmal nocturnal hemoglobinuria (PNH) who had not recently taken a C5 complement inhibitor medicine received pegcetacoplan or supportive care. Pegcetacoplan reduced hemolysis better than supportive care and was well tolerated.
ISSN:	2399-5262 2399-5270 2399-5270
DOI:	10.2217/frd-2023-0006